Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma.
about
Stathmin-dependent molecular targeting therapy for malignant tumor: the latest 5 years' discoveries and developmentsMELK: a potential novel therapeutic target for TNBC and other aggressive malignancies.Use of nanoparticles for glioblastoma treatment: a new approach.The effect of downregulation of Stathmin gene on biological behaviors of U373 and U87-MG glioblastoma cells.
P2860
Stathmin involvement in the maternal embryonic leucine zipper kinase pathway in glioblastoma.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
Stathmin involvement in the ma ...... inase pathway in glioblastoma.
@ast
Stathmin involvement in the ma ...... inase pathway in glioblastoma.
@en
type
label
Stathmin involvement in the ma ...... inase pathway in glioblastoma.
@ast
Stathmin involvement in the ma ...... inase pathway in glioblastoma.
@en
prefLabel
Stathmin involvement in the ma ...... inase pathway in glioblastoma.
@ast
Stathmin involvement in the ma ...... inase pathway in glioblastoma.
@en
P2093
P2860
P1433
P1476
Stathmin involvement in the ma ...... kinase pathway in glioblastoma
@en
P2093
Gisele Nunes Reis
Jean-Pierre Tassan
Jose Cesar Rosa
Marcela Gimenez
Miyuki Uno
Roseli da Silva
Sueli Mieko Oba-Shinjo
P2860
P2888
P356
10.1186/S12953-016-0094-9
P577
2016-03-11T00:00:00Z
P5875
P6179
1009769889